FDC
Back to Cashflow Statement
|
FDC Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-93 Cr | ₹-92 Cr | ₹-202 Cr | ₹-180 Cr | ₹-9.84 Cr |
What is the latest Cash Flow from Financing Activities ratio of FDC ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-93 Cr |
| Mar2025 | ₹-92 Cr |
| Mar2024 | ₹-202 Cr |
| Mar2023 | ₹-180 Cr |
| Mar2022 | ₹-9.84 Cr |
How is Cash Flow from Financing Activities of FDC Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-93 Cr | Negative | |
| Mar2025 | ₹-92 Cr | Negative | |
| Mar2024 | ₹-202 Cr | Negative | |
| Mar2023 | ₹-180 Cr | Negative | |
| Mar2022 | ₹-9.84 Cr | - | |
Compare Cash Flow from Financing Activities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹5,538.5 Cr | -3.2% | -6.2% | -22.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,831.0 Cr | -0.4% | -6.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹242,074.0 Cr | 0.9% | -3.3% | 39.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,355.0 Cr | 0.1% | -7.2% | 28.2% | Stock Analytics | |
| CIPLA | ₹107,439.0 Cr | -0.3% | -4% | -15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,417.0 Cr | 1.5% | 3.1% | 0.4% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -3.2% |
-6.2% |
-22.1% |
| SENSEX | 0.6% |
-1.4% |
-10.7% |
You may also like the below Video Courses